Literature DB >> 11173580

nm23-H1 Expression in Squamous Cell Carcinoma of the Head and Neck.

John S McDonald1, Peter S Gartside, Ljiljana J Pavelic, Jack L Gluckman, Zlatko P Pavelic.   

Abstract

Archival material from 47 patients with primary squamous cell carcinoma of the head and neck (SCCHN) was studied immunohistochemically for the presence of nm23-H1 protein. Our data indicate that nm23-H1 protein expression is a common event in SCCHN and that there is a trend toward correlation of increased expression of nm23-H1 with increasing tumor size (p = 0.072). The results also show that when adjusting for age and cause of death, there tended to be an inverse relationship between overall survival and the expression of nm23-H1 gene in the primary tumor (p = 0.088).

Entities:  

Year:  1996        PMID: 11173580     DOI: 10.1007/bf02893945

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  16 in total

Review 1.  Tumor metastasis and nm23: current concepts.

Authors:  P S Steeg; K H Cohn; A Leone
Journal:  Cancer Cells       Date:  1991-07

2.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.

Authors:  G Bevilacqua; M E Sobel; L A Liotta; P S Steeg
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

3.  Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma.

Authors:  K H Cohn; F S Wang; F Desoto-LaPaix; W B Solomon; L G Patterson; M R Arnold; J Weimar; J G Feldman; A T Levy; A Leone
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

4.  Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.

Authors:  E Campo; R Miquel; P Jares; F Bosch; M Juan; A Leone; J Vives; A Cardesa; J Yague
Journal:  Cancer       Date:  1994-06-15       Impact factor: 6.860

5.  Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

Authors:  V A Flørenes; S Aamdal; O Myklebost; G M Maelandsmo; O S Bruland; O Fodstad
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

6.  Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.

Authors:  A Leone; R C Seeger; C M Hong; Y Y Hu; M J Arboleda; G M Brodeur; D Stram; D J Slamon; P S Steeg
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

7.  High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages.

Authors:  M Engel; B Theisinger; T Seib; G Seitz; H Huwer; K D Zang; C Welter; S Dooley
Journal:  Int J Cancer       Date:  1993-09-30       Impact factor: 7.396

8.  Squamous cell carcinoma of the lung: does the nm23 gene expression correlate to the tumor stage?

Authors:  H Huwer; M Engel; C Welter; S Dooley; G Kalweit; P Feindt; E Gams
Journal:  Thorac Cardiovasc Surg       Date:  1994-10       Impact factor: 1.827

9.  Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value.

Authors:  M Higashiyama; O Doi; H Yokouchi; K Kodama; S Nakamori; R Tateishi; N Kimura
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

10.  Reduced expression of nm23 is associated with metastasis of human gastric carcinomas.

Authors:  H Nakayama; W Yasui; H Yokozaki; E Tahara
Journal:  Jpn J Cancer Res       Date:  1993-02
View more
  2 in total

1.  Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma.

Authors:  G Répássy; C Forster-Horváth; A Juhász; R Adány; A Tamássy; J Tímár
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

2.  Significance of SHP-1 and SHP-2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer.

Authors:  Xiao-hua Tao; Jian-gen Shen; Wei-li Pan; Yu-e Dong; Qun Meng; Kenneth V Honn; Rongxian Jin
Journal:  Pathol Oncol Res       Date:  2008-06-10       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.